|
|
|
Insider
Information: |
Henney Christopher S |
Relationship: |
Director |
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,304,748 |
|
Indirect Shares
|
100,000 |
|
|
Direct
Value |
$15,372 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,404,748 |
|
|
Total
Value |
$15,372 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-56.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dendreon Corp |
DNDN |
Chaiman of the Board, ... |
2004-02-17 |
1,062,904 |
2003-07-28 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2004-09-17 |
0 |
2003-08-20 |
0 |
Premium* |
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director |
2008-08-20 |
0 |
|
0 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2007-12-10 |
0 |
Premium* |
|
Anthera Pharmaceuticals Inc |
ANTH |
Director |
2012-06-29 |
202,429 |
2012-06-29 |
100,000 |
Premium* |
|
Prothena Corp Plc |
PRTA |
Director |
2021-07-14 |
0 |
2015-08-07 |
0 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
Director |
2023-06-30 |
39,415 |
2021-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ANTH |
Anthera Pharmaceuticals I... |
Director |
|
2010-02-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,602 |
|
- |
|
ANTH |
Anthera Pharmaceuticals I... |
Director |
|
2010-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
46,940 |
61,542 |
0 |
- |
|
ANTH |
Anthera Pharmaceuticals I... |
Director |
|
2010-04-01 |
4 |
OE |
$0.26 |
$49,473 |
D/D |
40,887 |
102,429 |
0 |
- |
|
ANTH |
Anthera Pharmaceuticals I... |
Director |
|
2012-06-29 |
4 |
B |
$0.75 |
$74,930 |
D/D |
100,000 |
202,429 |
2.39 |
- |
|
ANTH |
Anthera Pharmaceuticals I... |
Director |
|
2012-06-29 |
4 |
B |
$0.75 |
$74,930 |
I/I |
100,000 |
100,000 |
2.1 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2007-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2009-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,185 |
31,185 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2010-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,086 |
39,271 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2010-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,166 |
42,437 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,538 |
46,975 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,076 |
49,051 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-10-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
99,051 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-11-18 |
4 |
D |
$6.36 |
$79,500 |
D/D |
(12,500) |
86,551 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-12-01 |
4 |
D |
$6.92 |
$43,250 |
D/D |
(6,250) |
105,301 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
111,551 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-12-04 |
4 |
D |
$6.86 |
$10,606 |
D/D |
(1,546) |
103,755 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-12-31 |
4 |
D |
$7.58 |
$4,525 |
D/D |
(597) |
105,546 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,388 |
106,143 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2012-05-03 |
4 |
D |
$4.15 |
$1,025 |
D/D |
(247) |
106,288 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2012-05-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
989 |
106,535 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2012-06-03 |
4 |
D |
$3.51 |
$7,094 |
D/D |
(2,021) |
104,267 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2012-06-07 |
4 |
A |
$3.67 |
$29,999 |
D/D |
8,174 |
112,441 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2013-06-09 |
4 |
D |
$1.86 |
$2,111 |
D/D |
(1,135) |
111,306 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2014-03-11 |
4 |
D |
$3.65 |
$17,659 |
D/D |
(4,838) |
125,820 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2014-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,352 |
130,658 |
0 |
- |
|
78 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|